99 related articles for article (PubMed ID: 22771636)
1. Inhibition of fatty acid synthase supresses osteosarcoma cell invasion and migration.
Liu ZL; Zhou Y; Luo QF; Hu M; Wang G; Huang SH; Shu Y
Indian J Pathol Microbiol; 2012; 55(2):163-9. PubMed ID: 22771636
[TBL] [Abstract][Full Text] [Related]
2. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro.
Wang TF; Wang H; Peng AF; Luo QF; Liu ZL; Zhou RP; Gao S; Zhou Y; Chen WZ
Biochem Biophys Res Commun; 2013 Oct; 440(2):229-34. PubMed ID: 24041695
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting valosin-containing protein suppresses osteosarcoma cell metastasis via AKT/nuclear factor of kappa B signaling pathway in vitro.
Long XH; Zhang ZH; Liu ZL; Huang SH; Luo QF
Indian J Pathol Microbiol; 2013; 56(3):190-5. PubMed ID: 24152492
[TBL] [Abstract][Full Text] [Related]
5. Positive feedback regulation between Akt phosphorylation and fatty acid synthase expression in osteosarcoma.
Wang H; Luo QF; Peng AF; Long XH; Wang TF; Liu ZL; Zhang GM; Zhou RP; Gao S; Zhou Y; Chen WZ
Int J Mol Med; 2014 Mar; 33(3):633-9. PubMed ID: 24366211
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.
Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA
Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362
[TBL] [Abstract][Full Text] [Related]
7. Interaction between fatty acid synthase and human epidermal growth receptor 2 (HER2) in osteosarcoma cells.
Long XH; Zhao K; Zhang GM; Zhou Y; Zhou RP; Liu ZL; Zhang ZH
Int J Clin Exp Pathol; 2014; 7(12):8777-83. PubMed ID: 25674245
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of fatty acid synthase suppresses osteosarcoma cell invasion and migration via downregulation of the PI3K/Akt signaling pathway in vitro.
Liu ZL; Mao JH; Peng AF; Yin QS; Zhou Y; Long XH; Huang SH
Mol Med Rep; 2013 Feb; 7(2):608-12. PubMed ID: 23229760
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of fatty-acid synthase suppresses P-AKT and induces apoptosis in bladder cancer.
Jiang B; Li EH; Lu YY; Jiang Q; Cui D; Jing YF; Xia SJ
Urology; 2012 Aug; 80(2):484.e9-15. PubMed ID: 22554590
[TBL] [Abstract][Full Text] [Related]
11. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB
Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells.
Deepa PR; Vandhana S; Jayanthi U; Krishnakumar S
Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):494-503. PubMed ID: 22151915
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid synthase inhibition induces differential expression of genes involved in apoptosis and cell proliferation in ocular cancer cells.
Deepa PR; Vandhana S; Krishnakumar S
Nutr Cancer; 2013; 65(2):311-6. PubMed ID: 23441619
[TBL] [Abstract][Full Text] [Related]
15. Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma.
Sun T; Zhong X; Song H; Liu J; Li J; Leung F; Lu WW; Liu ZL
Cell Death Dis; 2019 Apr; 10(4):298. PubMed ID: 30931932
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells.
Benassi MS; Chiechi A; Ponticelli F; Pazzaglia L; Gamberi G; Zanella L; Manara MC; Perego P; Ferrari S; Picci P
Cancer Lett; 2007 Jun; 250(2):194-205. PubMed ID: 17113707
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid synthase inhibitors induce apoptosis in non-tumorigenic melan-a cells associated with inhibition of mitochondrial respiration.
Rossato FA; Zecchin KG; La Guardia PG; Ortega RM; Alberici LC; Costa RA; Catharino RR; Graner E; Castilho RF; Vercesi AE
PLoS One; 2014; 9(6):e101060. PubMed ID: 24964211
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
[TBL] [Abstract][Full Text] [Related]
19. Vasodilator-stimulated phosphoprotein regulates osteosarcoma cell migration.
Wu G; Wei L; Yu A; Zhang M; Qi B; Su K; Hu X; Wang J
Oncol Rep; 2011 Dec; 26(6):1609-15. PubMed ID: 21874265
[TBL] [Abstract][Full Text] [Related]
20. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]